<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Immunology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Immunology</journal-title><trans-title-group xml:lang="ru"><trans-title>Russian Journal of Immunology</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-7221</issn><issn publication-format="electronic">2782-7291</issn><publisher><publisher-name xml:lang="en">Russian Society of Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">425</article-id><article-id pub-id-type="doi">10.31857/S102872210006502-7</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CONTENT OF GALECTINS-2, -9 AND SUBPOPULATIONS OF BLOOD MONOCYTES IN PATHOLOGY OF LUNG INFECTIOUS AND NON-INFECTIOUS GENESIS</article-title><trans-title-group xml:lang="ru"><trans-title>СОДЕРЖАНИЕ ГАЛЕКТИНОВ-2, -9 И СУБПОПУЛЯЦИЙ МОНОЦИТОВ КРОВИ ПРИ ПАТОЛОГИИ ЛЕГКИХ ИНФЕКЦИОННОГО И НЕИНФЕКЦИОННОГО ГЕНЕЗА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chumakovа</surname><given-names>S. P.</given-names></name><name xml:lang="ru"><surname>Чумакова</surname><given-names>С. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Doctor of Medical Sciences, Professor at the Department of Pathophysiology,</p><p>Tomsk</p></bio><bio xml:lang="ru"><p>д. м. н., профессор кафедры патофизиологии,</p><p>Томск</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vins</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Винс</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Assistant at the Department of Pathophysiology,</p><p>Tomsk</p></bio><bio xml:lang="ru"><p>ассистент кафедры патофизиологии,</p><p>634050 Томск, Московский тр., 2</p></bio><email>wmw_1991@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Urazovа</surname><given-names>O. I.</given-names></name><name xml:lang="ru"><surname>Уразова</surname><given-names>О. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Doctor of Medical Sciences, Professor, Corresponding Member of the RAS, Head of the Department of Pathophysiology,</p><p>Tomsk</p></bio><bio xml:lang="ru"><p>д. м. н., профессор, член-корр. РАН, заведующий кафедрой патофизиологии,</p><p>Томск</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bukreeva</surname><given-names>E. B.</given-names></name><name xml:lang="ru"><surname>Букреева</surname><given-names>Е. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Doctor of Medical Sciences, Professor of the Department of Internal Medicine Propaedeutics with the course of therapy of the Pediatric faculty,</p><p>Tomsk</p></bio><bio xml:lang="ru"><p>д. м. н., профессор кафедры пропедевтики внутренних болезней с курсом терапии педиатрического факультета,</p><p>Томск</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bulanova</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Буланова</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD of Medical Sciences, Assistant of the Department of Internal Medicine Propaedeutics with the course of therapy of the Pediatric Faculty,</p><p>Tomsk</p></bio><bio xml:lang="ru"><p>к. м. н., ассистент кафедры пропедевтики внутренних болезней с курсом терапии педиатрического факультета,</p><p>Томск</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Churinа</surname><given-names>E. G.</given-names></name><name xml:lang="ru"><surname>Чурина</surname><given-names>Е. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Doctor of Medical Sciences, Professor at the Department of Pathophysiology,</p><p>Tomsk</p></bio><bio xml:lang="ru"><p>д. м. н., профессор кафедры патофизиологии,</p><p>Томск</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sitnikovа</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Ситникова</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Postgraduate at the Department of Pathophysiology,</p><p>Tomsk</p></bio><bio xml:lang="ru"><p>аспирант кафедры патофизиологии,</p><p>Томск</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Novitsky</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Новицкий</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Doctor of Medical Sciences, Professor, Academician of the RAS, Honored Scientist of the Russian Federation, Professor of the Department of Pathophysiology,</p><p>Tomsk</p></bio><bio xml:lang="ru"><p>д. м. н., профессор, академик РАН, заслуженный деятель науки РФ, профессор кафедры патофизиологии,</p><p>Томск</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Siberian State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Сибирский государственный медицинский университет» Минздрава РФ</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-07-15" publication-format="electronic"><day>15</day><month>07</month><year>2019</year></pub-date><volume>22</volume><issue>2-2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>966</fpage><lpage>968</lpage><history><date date-type="received" iso-8601-date="2020-07-29"><day>29</day><month>07</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-07-29"><day>29</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Chumakovа S.P., Vins M.V., Urazovа O.I., Bukreeva E.B., Bulanova A.A., Churinа E.G., Sitnikovа A.V., Novitsky V.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, Чумакова С.П., Винс М.В., Уразова О.И., Букреева Е.Б., Буланова А.А., Чурина Е.Г., Ситникова А.В., Новицкий В.В.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Chumakovа S.P., Vins M.V., Urazovа O.I., Bukreeva E.B., Bulanova A.A., Churinа E.G., Sitnikovа A.V., Novitsky V.V.</copyright-holder><copyright-holder xml:lang="ru">Чумакова С.П., Винс М.В., Уразова О.И., Букреева Е.Б., Буланова А.А., Чурина Е.Г., Ситникова А.В., Новицкий В.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://rusimmun.ru/jour/article/view/425">https://rusimmun.ru/jour/article/view/425</self-uri><abstract xml:lang="en"><p>15 patients with infiltrative pulmonary tuberculosis (TB), 16 patients with chronic obstructive pulmonary disease (COPD) and 12 healthy donors were examined. Amount of CD14<sup>hi</sup>CD16<sup>–</sup>, CD14<sup>hi</sup>CD16<sup>lo</sup>, CD14<sup>lo</sup>CD16<sup>lo</sup> and CD14<sup>lo</sup>CD16<sup>–</sup> monocytes in the blood was evaluated by flow-cytometry, and galectin-2 and -9 concentration was measured by ELISA. Increase in the number of CD14<sup>hi</sup>CD16<sup>lo</sup> monocytes, differentiated from the CD14<sup>hi</sup>CD16<sup>–</sup> cells, and decrease in the content of galectin-2 and CD14<sup>lo</sup> CD16<sup>–</sup> monocytes in the blood were characteristic of TB. In COPD, an increase in the concentration of galectin-9 and the proportion of CD14<sup>hi</sup>CD16<sup>–</sup> monocytes against the background of deficiency of other their subpopulations in the blood was noted. </p></abstract><trans-abstract xml:lang="ru"><p>Обследовано 15 больных инфильтративным туберкулезом легких (ТЛ), 16 больных хронической обструктивной болезни легких (ХОБЛ) и 12 здоровых доноров, в крови которых оценивали относительное количество CD14<sup>hi</sup>CD16<sup>–</sup>, CD14<sup>hi</sup>CD16<sup>lo</sup>, CD14<sup>lo</sup>CD16<sup>lo</sup> и CD14<sup>lo</sup>CD16<sup>–</sup> моноцитов методом проточной цитофлуориметрии и концентрацию галектинов-2 и -9 методом иммуноферментного анализа. Показано, что для ТЛ характерно увеличение числа CD14<sup>hi</sup>CD16<sup>lo</sup> моноцитов, дифференцирующихся из CD14<sup>hi</sup>CD16<sup>–</sup> клеток, при снижении концентрации галектина-2 и количества CD14<sup>lo</sup>CD16<sup>–</sup> моноцитов в крови. При ХОБЛ отмечается увеличение концентрации галектина-9 и доли CD14<sup>hi</sup>CD16<sup>–</sup> моноцитов на фоне дефицита остальных субпопуляций этих клеток в крови. </p></trans-abstract><kwd-group xml:lang="en"><kwd>galectins</kwd><kwd>monocytes subpopulations</kwd><kwd>chronic obstructive pulmonary disease</kwd><kwd>tuberculosis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>галектины</kwd><kwd>субпопуляции моноцитов</kwd><kwd>хроническая обструктивная болезнь легких</kwd><kwd>туберкулез</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование поддержано грантами РФФИ (договор № 18-015-00160/18) и Совета по грантам Президента РФ (НШ-2690.2018.7 и МД-2788.2019.7).</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Yildirim C., Vogel D. Y., Hollander M. R., Baggen J. M., Fontĳ n R. D., Nieuwenhuis S., Haverkamp A., de Vries M. R., Quax P. H., Garcia-Vallejo J. J., van der Laan A. M., Dĳ kstra C. D., van der PouwKraan T.C., van Royen N., Horrevoets A. J. Galectin-2 induces a proinflammatory, anti-arteriogenic phenotype in monocytes and macrophages. PLoS One, 2015, 10, 4, e0124347.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Enninga E. A., Nevala W. K., Holtan S. G., Leontovich A. A., Markovic S. N. Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma. Melanoma Res., 2016, 26, 5, 429–441.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Barisionea C., Garibaldia S., Ghigliottia G., Fabbia P., Altieria P., Casalea M., Spallarossaa P., Berteroa G., Balbia M., Corsigliab L., Brunellia C. CD14CD16 monocyte subset levels in heart failure patients. Dis. Markers, 2010, 115–124.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Ханин А. Л., Кравец С. Л. Хроническая обструктивная болезнь легких и туберкулез: актуальная проблема в реальной практике (обзор литературы). Вестник современной клинической медицины, 2017, 6, 60–70.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Chihara М., Kurita М., Yoshihara Y., Asahina A., and Yanaba K. Clinical Significance of Serum Galectin-9 and Soluble CD155 Levels in Patients with Systemic Sclerosis. J Immunol Res. 2018, 9473243.</mixed-citation></ref></ref-list></back></article>
